- Home Professor Karen Canfell
Professor Karen Canfell
Karen is a cancer epidemiologist and was Director of Cancer Research at Cancer Council NSW, the inaugural Director of the Daffodil Centre, and Adjunct Professor at Sydney Medical School, University of Sydney. Karen holds a D.Phil. (PhD equivalent) in Epidemiology from the University of Oxford.
Prior to joining Cancer Council NSW, Karen headed up the Cancer Screening Group at the Lowy Cancer Research Centre at UNSW.
Karen’s research group regularly perform evaluations of new cancer screening and diagnostic technologies for government agencies in Australia, New Zealand and England. Her team’s work underpins the findings of a recent major review of the Australian National Cervical Screening Program and has resulted in the imminent transition of the program to 5-yearly HPV testing for cervical screening. Karen is also co-Principal Investigator of the first ever large-scale trial of cervical screening in a population offered HPV vaccination, ‘Compass’, which is being conducted with the Victorian Cytology Service. She is also a member of the Australian Medical Services Advisory Committee’s Protocol Advisory Sub-Committee.
In 2015, Karen received a ‘100 women of Influence’ nomination in the AFR/Westpac awards and also received a Research Excellence Award from the National Health and Medical Research Council. She has 100+ peer-review publications/government reports, is regularly invited to speak at international and national conferences, and is active on the scientific faculties for the major international conferences in her field.
Recent articles by Professor Karen Canfell

Cancer Council NSW is excited to announce that nearly $6million has been awarded to 15 ground-breaking cancer research projects. The grants help fund future breakthroughs in cancer research, with 15 of Australia’s leading research teams paving the way for new ways to treat the disease. The project grants were awarded on Wednesday 1 March at […]

Australia has been at the forefront of cervical cancer prevention for decades, and continues to take the lead – we are the first nation in the world to implement large-scale changes to cervical screening as a direct response to the successful implementation of HPV vaccination. This year, the National Cervical Screening Program is due to […]

Image courtesy of University of Queensland Faculty of Medicine. We have now reached a huge milestone in cervical cancer prevention: every woman in Australia aged 35 years and younger is better protected against HPV than ever before. HPV – the human papillomavirus – is the cause of virtually all cervical cancers, so this is a […]

At Cancer Council NSW, we get a lot of questions about our research into pancreatic cancer. Despite improvements in survival rates across more common types of cancer, only 6% of people diagnosed with pancreatic cancer will survive past five years. However, the researchers that we fund are making important steps forward in finding the answers […]

Professor Stuart Tangye from the Garvan Institute of Medical Research has been funded by Cancer Council NSW since 2002 for his pioneering research on the link between the immune system and cancer. Professor Tangye has just received a brand new grant from Cancer Council NSW, which could ultimately lead to a brand new cancer vaccine. […]

Cancer Council NSW is excited to announce that around $3.6 million in new funding has been awarded to some of Australia’s most outstanding researchers, who are setting out to reduce the impact of cancer and explore new treatment approaches. Who are the cancer researchers? A total of 10 visionary researchers and their teams were successful […]

Two research teams from the University of Newcastle have received over $4.4 million in funding to support their ground-breaking work. Cancer Council NSW awards these prestigious program grants, which run over 5 years, to the most outstanding researchers in the state with a track record of excellence. One grant has gone to Laureate Professor Rob […]